PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of adtMary Ann Liebert, Inc.Mary Ann Liebert, Inc.JournalsSearchAlerts
Assay and Drug Development Technologies
 
Assay Drug Dev Technol. 2010 October; 8(5): 621–624.
PMCID: PMC2957273

A Homogeneous Method to Measure Nucleotide Exchange by α-Subunits of Heterotrimeric G-Proteins Using Fluorescence Polarization

Abstract

The mainstay of assessing guanosine diphosphate release by the α-subunit of a heterotrimeric G-protein is the [35S]guanosine 5′-O-(3-thiotriphosphate) (GTPγS) radionucleotide-binding assay. This assay requires separation of protein-bound GTPγS from free GTPγS at multiple time points followed by quantification via liquid scintillation. The arduous nature of this assay makes it difficult to quickly characterize multiple mutants, determine the effects of individual variables (e.g., temperature and Mg2+ concentration) on nucleotide exchange, or screen for small molecule modulators of Gα nucleotide binding/cycling properties. Here, we describe a robust, homogeneous, fluorescence polarization assay using a red-shifted fluorescent GTPγS probe that can rapidly determine the rate of GTPγS binding by Gα subunits.

Introduction

Seven transmembrane-domain G-protein coupled receptors (GPCRs), along with their associated heterotrimeric G-proteins (Gα · guanosine diphosphate [GDP]/Gβ/Gγ), serve to transduce signals from diverse extracellular stimuli, such as photons, tastants, hormones, and neurotransmitters, to the intracellular compartment.13 Agonist binding to the GPCR elicits guanine nucleotide exchange factor (GEF) activity, resulting in receptor-catalyzed release of GDP by Gα and subsequent binding of guanosine triphosphate (GTP).4 The GTP-bound Gα subunit is the active signaling species, yet has an intrinsic ability to hydrolyze GTP back to GDP, which can be accelerated by a family of regulators of G-protein signaling (RGS proteins5). Historically, both receptor-catalyzed and spontaneous nucleotide release by Gα subunits has been measured using the radioactively labeled, nonhydrolyzable nucleotide [35S]guanosine 5′-O-(3-thiotriphosphate) (GTPγS).6 These radionucleotide binding assays typically involve incubation of [35S]GTPγS with the Gα subunit, followed by vacuum filtration, buffer washes, membrane dessication, and then quantification of protein-bound [35S]GTPγS by liquid scintillation.7 While producing reliable and accurate results, this method is tedious, generates radioactive waste, and is not easily amenable to automation. The use of membrane-immobilized scintillation proximity assay (SPA) beads has allowed several groups to develop high-throughput-screen (HTS)-compatible [35S]GTPγS assays810; however, inherent to the use of radionucleotides is the generation of unwanted radioactive waste. In an attempt to develop a nonradioactive, HTS-compatible GTPγS binding assay, others have reported using an europium-labeled GTPγS probe either in time-resolved fluorescence resonance energy transfer (TR-FRET)1113 or in quenching resonance energy transfer (QRET).14 The ability to use QRET in a homogenous format (i.e., without the need for separation of bound and unbound Eu-GTPγS) represents an advance over the earlier TR-FRET-based assays.15 Additional, non-lanthanide-based fluorescent GTP analogs have also led to the establishment of nonradioactive assays to quantify the nucleotide cycling properties of G-proteins1618; however, these alternate assays involve monitoring changes in the absolute intensity of the fluor as its local solvating environment changes upon binding or hydrolysis events. The need to measure absolute intensity change, coupled with the use of fluors in the green range, prevents these assays from being suitable for screening small molecule libraries for nucleotide-state modulators.19,20 Advances in plate readers capable of detecting fluorescence polarization (FP) and the commercial availability of red-shifted fluorescent-GTP analogs recently allowed Evelyn et al.21 to measure nucleotide exchange by small, Rho-subfamily GTPases using a BODIPY-Texas Red (TR)-GTPγS (Invitrogen). Here, we describe using this fluor-labeled GTPγS in a homogenous FP assay for measuring the rate of spontaneous nucleotide exchange by Gα subunits.

Materials and Methods

BODIPY-TR-GTPγS was purchased from Invitrogen and all other chemicals were purchased from Sigma at the highest quality obtainable. Two human Gα subunits were each separately expressed in Escherichia coli and purified in their GDP-bound forms by affinity chromatography exactly as previously described7,19: namely, wildtype Gαil and a double-point-mutant Gαi1(R178M/A326S) that we recently developed to have accelerated spontaneous GDP release and slowed GTP hydrolysis.7 FP experiments were conducted on the POLARStar Omega plate reader (BMG Labtech) containing a dichroic mirror and a dual emission beam splitter to measure fluorescence intensity parallel (F||) and perpendicular (F[perpendicular]) to the excitation plane. Samples were excited at 584 nm (excitation filter range of 566–588 nm) and emission was detected at 630 nm (cutoff ± 5 nm). The photomultiplier tubes were calibrated so that 25 nM TR-GTPγS in assay buffer (10 mM Tris-HCl pH 7.5, 50 mM NaCl, 10 mM MgCl2, and 0.05% (v/v) NP40 alternative) had a polarization of ~ 35 mP. Polarization was calculated as P = (F||  F[perpendicular])/(F|| + F[perpendicular]) and expressed as mP (“milliP” or 1000*P); fluorescence intensity was calculated as I = F|| + 2F[perpendicular]. Trials were conducted at 26°C using Corning Black Polystyrene 96-well plates (cat# CLS3875; Sigma). Gαil was diluted to 500 nM in assay buffer and plated at an initial volume of 180 μL/well. Experiments were initiated upon addition of 20 μL of 250 nM TR-GTPγS to each well (25 nM TR-GTPγS final concentration). All experiments were conducted at least in triplicate. Nonlinear regression was used to fit the data to a single exponential association curve without constraints to calculate the kobs using Prism version 5.0c (GraphPad).

To compare results obtained by the FP assay with the traditional radioactivity-based assay, radionucleotide binding assays were performed in parallel as previously described.22 Briefly, assays were initiated by addition of [35S]GTPγS to 100 nM wildtype Gαi1 or Gαi1(R178M/A326S) mutant, either in assay buffer or in assay buffer containing 100 μM GTPγS. At indicated time points, aliquots were filtered by vacuum through nitrocellulose membranes and washed with ice-cold buffer. Assays were conducted in duplicate and error bars represent standard error of the mean. Nonspecific binding was subtracted from all time points. Nonlinear regression and statistical analyses were performed in Prism version 5.

Results

Using the TR-GTPγS FP assay, observed rates of GTPγS binding (kobs) were determined to be 0.0013 s−1 (95% CI 0.0011–0.0015 s−1) and 0.0078 s−1 (95% CI 0.0063–0.0092 s−1) for wildtype Gαi1 and the double-mutant Gαi1(R178M/A326S), respectively (Fig. 1A); the greater kobs for the latter Gα subunit is wholly consistent with its known increased rate of spontaneous GDP release and thus faster GTP binding.7 The change in total intensity (Fig. 1B) was independently used to determine the kobs for both Gαi1 subunits: rates of GTPγS binding for wildtype Gαi1 and Gαi1(R178M/A326S) were determined to be 0.0016 s−1 (95% CI 0.0015–0.0016 s−1) and 0.010 s−1 (95% CI 0.009–0.011 s−1), respectively. Both the FP and fluorescence intensity results are consistent with the data obtained using the [35S]-GTPγS radionucleotide binding assay (Fig. 1C), performed exactly as previously described.22 Values of kobs using [35S]-GTPγS binding were determined to be 0.0019 s−1 (95% CI 0.0015–0.0023 s−1) and 0.0090 s−1 (95% CI 0.007–0.0100 s−1) for wildtype Gαi1 and Gαi1(R178M/A326S), respectively. While measuring fluorescence intensity and FP both allow monitoring of TR-GTPγS binding to an α-subunit of a heterotrimeric G-protein, measuring FP is considered superior given that it is a ratiometric measurement and thus less sensitive to interference from compounds that absorb or fluoresce in the same spectral region.

Fig. 1.
Fluorescence-based Texas Red (TR)-guanosine 5′-O-(3-thiotriphosphate) (GTPγS) binding assay produces the same results as the gold-standard, [35S]GTPγS radionucleotide binding assay. (A) Fluorescence polarization (FP) was measured ...

To validate the sensitivity of the TR-GTPγS FP assay with respect to changes in spontaneous GDP release, we used the Gαi1 · GDP-binding peptide AGS3Con, derived from the consensus of the 4 GoLoco motifs of AGS3 (TMGEEDFFDLLAKSQSKRMDDQRVDLAG; ref.23) and known to exhibit GDP dissociation inhibitory activity toward Gαi · GDP subunits.24,25 A dramatic decrease in the rate of TR-GTPγS binding was observed using FP upon addition of 10 μM AGS3Con peptide to wildtype Gαi1, as expected (Fig. 2).23 The rate of TR-GTPγS binding decreased from 0.0013 s−1 (95% CI 0.0012–0.0014 s−1) for wildtype Gαi1 alone, to 0.0004 s−1 (95% CI 0.0003–0.0005 s−1) for Gαi1 plus AGS3Con peptide. The addition of a 200-fold excess of nonfluorescent GTPγS was able to compete away completely any change in FP signal over the indicated time interval (Fig. 2), indicating that the TR-GTPγS does not bind nonspecificially to Gαi1. To establish that this TR-GTPγS FP assay was not specific to a single plate reader, we also performed this assay on an EnVision Alpha HTS plate reader (Perkin-Elmer) and observed similar results (data not shown).

Fig. 2.
The GoLoco motif peptide AGS3Con and unlabeled guanosine 5′-O-(3-thiotriphosphate) (GTPγS) both inhibit Texas Red (TR)-GTPγS binding to Gαi1. AGS3Con peptide (10 μM; -
An external file that holds a picture, illustration, etc.
Object name is inl-3.jpg
-, light gray), unlabeled GTPγS
...

Conclusion

We have described a robust, “mix-and-measure,” fluorescence-based assay system for measuring GTP binding activity by an α-subunit of a heterotrimeric G-protein. The TR-GTPγS FP assay should work universally for any Gα subunit, requires no radioactivity, and produces results consistent with radionucleotide binding assays. For researchers without the ability or desire to use radionucleotide binding assays, the TR-GTPγS FP assay offers a safer alternative. Additionally, performing this assay with the 96-well plate reader offers the advantage of automation (e.g., screening chemical libraries, profiling hits, and performing these assays on multiple Gα isoforms or multiple Gα point mutants). On the basis of its ability to detect differences in the rates of spontaneous GDP release by wildtype Gαi1 versus the Gαi1(R178M/A326S) mutant, we expect this assay to be readily utilized in assessing the GEF activity of GPCRs and nonreceptor Gα-GEFs such as Arr4 and RIC-8.26,27

Abbreviations

FP
fluorescence polarization
GDP
guanosine diphosphate
GEF
guanine nucleotide exchange factor
GPCR
G-protein coupled receptor
GTP
guanosine triphosphate
GTPgS
guanosine 5′-O-(3-thiotriphosphate)
HTS
high-throughput screen
QRET
quenching resonance energy transfer
SPA
scintillation proximity assay
TR
Texas Red
TR-FRET
time-resolved fluorescence resonance energy transfer

Acknowledgments

Work in the Siderovski lab was supported by NIH grant R01 GM082892. R.E.M., K.R.K., and A.J.K. acknowledge early support from NIH training grant T32 GM008719, and A.J.K. acknowledges current support from NIH fellowship F30 MH074266.

References

1. Gilman AG. G proteins: transducers of receptor-generated signals. Annu Rev Biochem. 1987;56:615–649. [PubMed]
2. Pierce KL. Premont RT. Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev Mol Cell Biol. 2002;3:639–650. [PubMed]
3. Wettschureck N. Offermanns S. Mammalian G proteins and their cell type specific functions. Physiol Rev. 2005;85:1159–1204. [PubMed]
4. Johnston CA. Siderovski DP. Receptor-mediated activation of heterotrimeric G-proteins: current structural insights. Mol Pharmacol. 2007;72:219–230. [PubMed]
5. Lambert NA. Johnston CA. Cappell SD. Kuravi S. Kimple AJ. Willard FS, et al. Regulators of G-protein signaling accelerate GPCR signaling kinetics and govern sensitivity solely by accelerating GTPase activity. Proc Natl Acad Sci USA. 2010;107:7066–7071. [PubMed]
6. Ross EM. Quantitative assays for GTPase-activating proteins. Methods Enzymol. 2002;344:601–617. [PubMed]
7. Zielinski T. Kimple AJ. Hutsell SQ. Koeff MD. Siderovski DP. Lowery RG. Two Gαi1 rate-modifying mutations act in concert to allow receptor-independent, steady-state measurements of RGS protein activity. J Biomol Screen. 2009;14:1195–1206. [PMC free article] [PubMed]
8. Dallas-Yang Q. Qureshi SA. Xie D. Zhang BB. Jiang G. Detection of glucagon-dependent GTPgammaS binding in high-throughput format. Anal Biochem. 2002;301:156–159. [PubMed]
9. Ferrer M. Kolodin GD. Zuck P. Peltier R. Berry K. Mandala SM, et al. A fully automated [35S]GTPgammaS scintillation proximity assay for the high-throughput screening of Gi-linked G protein-coupled receptors. Assay Drug Dev Technol. 2003;1:261–273. [PubMed]
10. Rodgers G. Hubert C. McKinzie J. Suter T. Statnick M. Emmerson P, et al. Development of displacement binding and GTPgammaS scintillation proximity assays for the identification of antagonists of the micro-opioid receptor. Assay Drug Dev Technol. 2003;1:627–636. [PubMed]
11. Frang H. Mukkala VM. Syysto R. Ollikka P. Hurskainen P. Scheinin M, et al. Nonradioactive GTP binding assay to monitor activation of g protein-coupled receptors. Assay Drug Dev Technol. 2003;1:275–280. [PubMed]
12. Labrecque J. Anastassov V. Lau G. Darkes M. Mosi R. Fricker SP. The development of an europium-GTP assay to quantitate chemokine antagonist interactions for CXCR4 and CCR5. Assay Drug Dev Technol. 2005;3:637–648. [PubMed]
13. Labrecque J. Wong RS. Fricker SP. A time-resolved fluorescent lanthanide (Eu)-GTP binding assay for chemokine receptors as targets in drug discovery. Methods Mol Biol. 2009;552:153–169. [PubMed]
14. Harma H. Rozwandowicz-Jansen A. Martikkala E. Frang H. Hemmila I. Sahlberg N, et al. A new simple cell-based homogeneous time-resolved fluorescence QRET technique for receptor-ligand interaction screening. J Biomol Screen. 2009;14:936–943. [PubMed]
15. Rozwandowicz-Jansen A. Laurila J. Martikkala E. Frang H. Hemmila I. Scheinin M, et al. Homogeneous GTP binding assay employing QRET technology. J Biomol Screen. 2010;15:261–267. [PubMed]
16. McEwen DP. Gee KR. Kang HC. Neubig RR. Fluorescent BODIPY-GTP analogs: real-time measurement of nucleotide binding to G proteins. Anal Biochem. 2001;291:109–117. [PubMed]
17. McEwen DP. Gee KR. Kang HC. Neubig RR. Fluorescence approaches to study G protein mechanisms. Methods Enzymol. 2002;344:403–420. [PubMed]
18. Willard FS. Kimple AJ. Johnston CA. Siderovski DP. A direct fluorescence-based assay for RGS domain GTPase accelerating activity. Anal Biochem. 2005;340:341–351. [PubMed]
19. Kimple AJ. Yasgar A. Hughes M. Jadhav A. Willard FS. Muller RE, et al. A high throughput fluorescence polarization assay for inhibitors of the GoLoco motif/G-alpha interaction. Comb Chem High Throughput Screen. 2008;11:396–409. [PMC free article] [PubMed]
20. Simeonov A. Jadhav A. Thomas CJ. Wang Y. Huang R. Southall NT, et al. Fluorescence spectroscopic profiling of compound libraries. J Med Chem. 2008;51:2363–2371. [PubMed]
21. Evelyn CR. Ferng T. Rojas RJ. Larsen MJ. Sondek J. Neubig RR. High-throughput screening for small-molecule inhibitors of LARG-stimulated RhoA nucleotide binding via a novel fluorescence polarization assay. J Biomol Screen. 2009;14:161–172. [PMC free article] [PubMed]
22. Johnston CA. Lobanova ES. Shavkunov AS. Low J. Ramer JK. Blaesius R, et al. Minimal determinants for binding activated G alpha from the structure of a G alpha(i1)-peptide dimer. Biochemistry. 2006;45:11390–11400. [PMC free article] [PubMed]
23. Kimple RJ. De Vries L. Tronchere H. Behe CI. Morris RA. Gist Farquhar M, et al. RGS12 and RGS14 GoLoco motifs are G alpha(i) interaction sites with guanine nucleotide dissociation inhibitor activity. J Biol Chem. 2001;276:29275–29281. [PubMed]
24. Siderovski DP. Willard FS. The GAPs, GEFs, and GDIs of heterotrimeric G-protein alpha subunits. Int J Biol Sci. 2005;1:51–66. [PMC free article] [PubMed]
25. Willard FS. Kimple RJ. Siderovski DP. Return of the GDI: the GoLoco motif in cell division. Annu Rev Biochem. 2004;73:925–951. [PubMed]
26. Afshar K. Willard FS. Colombo K. Johnston CA. McCudden CR. Siderovski DP, et al. RIC-8 is required for GPR-1/2-dependent Galpha function during asymmetric division of C. elegans embryos. Cell. 2004;119:219–230. [PubMed]
27. Lee MJ. Dohlman HG. Coactivation of G protein signaling by cell-surface receptors and an intracellular exchange factor. Curr Biol. 2008;18:211–215. [PMC free article] [PubMed]

Articles from Assay and Drug Development Technologies are provided here courtesy of Mary Ann Liebert, Inc.